November 25th 2024
Fluorescence spectroscopy offers unique advantages for characterizing EVs.
November 22nd 2024
November 21st 2024
The evolution of therapeutic modalities drives the adoption of single-use technologies.
Tools for Continuous Bioprocess Development
January 1st 2016In semiconductor manufacturing, for example, a thorough understanding of process variation allows companies to manufacture circuits with billions of transistors at high yields. These variations are translated into a set of design rules, which help ensure that designs will be manufactured successfully and meet safety and other regulatory requirements.
Precipitation as an Alternative to Chromatography in the Insulin Manufacturing Process
The authors explore the use of precipitation using polyvinyl sulfonic acid and zinc chloride in place of capture chromatography to reduce the cost of goods in the insulin manufacturing process.
Laminins Key to Production-Scale Stem Cell Development
November 30th 2015Growing differentiated cells from stem cells may now be a bit easier than before, thanks to the findings from a new study on the production of liver cells. The study, backed by the Centre for Regenerative Medicine and published in Stem Cell Reports, finds that laminins may be a crucial element for the successful clinical-scale production and culture of stem cell therapies. The UK Regenerative Medicine Platform, the European Union Seventh Framework Programme, and the German Federal Ministry of Education and Research funded the research.
Advancing Research on Cellular and Gene Therapies
November 20th 2015There’s renewed optimism in the biomedical research community that years of effort finally may begin to pay off for developing cutting-edge gene and cellular treatments for debilitating and life-threatening conditions. Jill Wechsler reports.
Pfizer Transfers Vaccine Technology for Production in South Africa
November 5th 2015South Africa’s Biovac Institute, which develops and produces vaccines for the country, launched a public-private partnership with Pfizer to enable local manufacturing of Prevenar 13, a vaccine against pneumonia-causing bacteria.